Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: inappropriate (103), incompatible (7)

Your stay at the major trauma centre - patient information

Description: This factsheet gives you useful information about your stay at the major trauma centre.
Url: /Media/UHS-website-2019/Patientinformation/Major-Trauma-Centre/Your-stay-at-the-major-trauma-centre-3125-PIL.pdf

Carboplatin-Pembrolizumab-Pemetrexed

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC 5)-PEMBROLIZUMAB-PEMETREXED Regimen • NSCLC – Carboplatin (AUC5)-Pembrolizumab-Peme
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Pembrolizumab-Pemetrexed.pdf

UHS Inclusion and Belonging Strategy

Description: Our strategy sets out clear actions we will take to make UHS a place where every person feels they belong and
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/uhs-inclusion-and-belonging-strategy.pdf

People and OD Committee ToR December 2022

Description: Terms of Reference from a People and Organisational Development Committee.
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/People-and-OD-Committee-ToR-December-2022.pdf

UHS Our People Strategy 2022 - 2026

Description: OUR PEOPLE STRATEGY 2022 to 2026 CONTENTS 05 Foreword by Steve Harris – chief people officer 06 Our strategic framework 07 Always Improv
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Plans-and-strategies/UHS-Our-People-Strategy-2022-2026.pdf

Erlotinib

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ERLOTINIB Regimen NSCLC - Erlotinib Indication Second line therapy of stage IIIB or IV NSCLC WHO Perf
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Erlotinibver12.pdf

Cisplatin-Pembrolizumab-Pemetrexed

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-PEMBROLIZUMAB-PEMETREXED Regimen • NSCLC – Cisplatin-Pembrolizumab-Pemetrexed Indication •
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Cisplatin-Pembrolizumab-Pemetrexed.pdf

Recovering well after breast surgery (sutures) - patient information

Description: This factsheet explains what to expect after having breast surgery (using sutures for wound closure) and how you can help your
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Recovering-well-after-breast-surgery-sutures-3099-PIL.pdf

Recovering well after breast surgery (glue) - patient information

Description: This factsheet explains what to expect after having breast surgery (using glue for wound closure) and how you can help your
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Recovering-well-after-breast-surgery-glue-3098-PIL.pdf

Cardio pulmonary exercise test (CPET) for children - patient information

Description: This factsheet provides information about your child having a cardio pulmonary exercise test (CPET).
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Cardio-pulmonary-exercise-test-CPET-for-children-640-PIL.pdf

261 to 270 of 314

Previous … 25 26 27 28 29 … Next